About Sagent Pharma
Sagent Pharma is a company based in Schaumburg (United States) founded in 2006 was acquired by Nichi-Iko Pharmaceutical in July 2016. Sagent Pharma has raised $153 million across 5 funding rounds from investors including MidCap Financial, Zhejiang Hisun Pharmaceuticals and Nichi-Iko Pharmaceutical. Sagent Pharma has completed 1 acquisition, including Omega Laboratory. Sagent Pharma offers products and services including Injectable Pharmaceuticals and PreventIV Measures Packaging.
- Headquarter Schaumburg, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sagent Pharma Services (India) Private Limited
- Date of Incorporation 09 Aug, 2023
- Jurisdiction Shaikpet, Telangana, India
-
Annual Revenue
$318.3 M (USD)10as on Dec 31, 2015
-
Net Profit
-$21.88 M (USD)-159as on Dec 31, 2015
-
EBITDA
-$44.52 M (USD)-334as on Dec 31, 2015
-
Total Equity Funding
$153 M (USD)
in 5 rounds
-
Latest Funding Round
$40 M (USD), Series B
Apr 05, 2010
-
Investors
MidCap Financial
& 3 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Nichi-Iko Pharmaceutical
(Jul 10, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sagent Pharma
Sagent Pharma offers a comprehensive portfolio of products and services, including Injectable Pharmaceuticals and PreventIV Measures Packaging.
Injectable drugs are supplied in various therapeutic categories and packaging configurations to meet healthcare needs.
Packaging and labeling services are offered to minimize medication errors in clinical environments.
People of Sagent Pharma
Unlock access to complete
Funding Insights of Sagent Pharma
Sagent Pharma has successfully raised a total of $153M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $40 million completed in April 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sagent Pharma
Sagent Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include MidCap Financial, Zhejiang Hisun Pharmaceuticals and Nichi-Iko Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt funds are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Venture capital and private equity firm
|
Locked | Locked | Locked | |
|
Pharmaceutical APIs, formulations, and animal health products are manufactured.
|
Locked | Locked | Locked |
Investor details for Sagent Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sagent Pharma
Sagent Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Omega Laboratory.
Investment portfolio details for Sagent Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Specialized sterile products are manufactured for hospitals and providers.
|
Locked | Locked | 1958 | Locked |
Complete acquisition details for Sagent Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sagent Pharma
Detailed financials for Sagent Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sagent Pharma Comparisons
Peer comparison for Sagent Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sagent Pharma
Detailed competitors of Sagent Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sagent Pharma
Complete news archive for Sagent Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sagent Pharma
Sagent Pharma was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Sagent Pharma is headquartered in Schaumburg, United States. It is registered at Schaumburg, Illinois, United States.
Sagent Pharma is a funded company, having raised a total of $153M across 5 funding rounds to date.
Annual revenue of Sagent Pharma is $318.3M as on Dec 31, 2015.
Sagent Pharma was founded in 2006 and is headquartered in Schaumburg, United States, within the pharmaceuticals sector. Injectable generic drugs are manufactured and distributed in formats such as vials, syringes, and premix bags. Products cover various therapeutic areas, with smart labeling implemented to minimize medication errors. Assistance is provided to healthcare providers and patients through dedicated support services.
Sagent Pharma offers Injectable Pharmaceuticals and PreventIV Measures Packaging.
Sagent Pharma has made 1 acquisition, including Omega Laboratory.
Sagent Pharma has 4 investors. Key investors include MidCap Financial, Zhejiang Hisun Pharmaceuticals, Nichi-Iko Pharmaceutical, and Vivo Capital.